# Invesco Mortgage Capital Inc.: financial statements, quarterly

IVR · NYSE · CIK 1437071 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ivr.md) · [Financials](/companies/ivr/financials.md) · [Filings](/companies/ivr/filings.md) · [Insiders](/companies/ivr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ivr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [65.7](/filings/0001437071-23-000033.md) | [53.8 d](/filings/0001437071-24-000005.md) | [61.6](/filings/0001437071-24-000016.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(68.6)](/filings/0001437071-24-000037.md) | [27.2 d](/filings/0001437071-26-000015.md) | [29.1](/filings/0001437071-25-000051.md) | [(13.5)](/filings/0001437071-25-000051.md) | [40.7](/filings/0001437071-25-000051.md) | [3.5 d](/filings/0001437071-26-000015.md) | [19.6](/filings/0001437071-26-000064.md) | [(23.3)](/filings/0001437071-26-000064.md) | [53.5](/filings/0001437071-25-000051.md) | [51.5 d](/filings/0001437071-26-000015.md) | [(19.9)](/filings/0001437071-26-000064.md) | [35.0](/filings/0001437071-26-000064.md) |
| Diluted EPS | $ per share | [(1.62)](/filings/0001437071-24-000037.md) | not reported | [0.49](/filings/0001437071-25-000017.md) | [(0.38)](/filings/0001437071-25-000031.md) | [0.63](/filings/0001437071-25-000051.md) | not reported | [0.26](/filings/0001437071-26-000038.md) | [(0.40)](/filings/0001437071-26-000064.md) | [0.74](/filings/0001437071-25-000051.md) | not reported | [(0.28)](/filings/0001437071-26-000038.md) | [0.34](/filings/0001437071-26-000064.md) |
| Basic EPS | $ per share | [(1.62)](/filings/0001437071-24-000037.md) | not reported | [0.49](/filings/0001437071-25-000017.md) | [(0.38)](/filings/0001437071-25-000031.md) | [0.63](/filings/0001437071-25-000051.md) | not reported | [0.26](/filings/0001437071-26-000038.md) | [(0.40)](/filings/0001437071-26-000064.md) | [0.74](/filings/0001437071-25-000051.md) | not reported | [(0.28)](/filings/0001437071-26-000038.md) | [0.34](/filings/0001437071-26-000064.md) |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [174](/filings/0001437071-23-000033.md) | [77.0](/filings/0001437071-25-000007.md) | [59.9](/filings/0001437071-24-000016.md) | [58.8](/filings/0001437071-24-000027.md) | [48.3](/filings/0001437071-24-000037.md) | [73.4](/filings/0001437071-26-000015.md) | [42.9](/filings/0001437071-25-000017.md) | [59.4](/filings/0001437071-25-000031.md) | [58.5](/filings/0001437071-25-000051.md) | [56.0](/filings/0001437071-26-000064.md) | [52.6](/filings/0001437071-26-000038.md) | [73.4](/filings/0001437071-26-000064.md) |
| Total assets | $m | [5,831](/filings/0001437071-23-000033.md) | [5,284](/filings/0001437071-25-000007.md) | [5,231](/filings/0001437071-24-000016.md) | [5,067](/filings/0001437071-24-000027.md) | [6,082](/filings/0001437071-24-000037.md) | [5,688](/filings/0001437071-26-000015.md) | [6,159](/filings/0001437071-25-000017.md) | [5,400](/filings/0001437071-25-000031.md) | [5,961](/filings/0001437071-25-000051.md) | [6,476](/filings/0001437071-26-000064.md) | [6,271](/filings/0001437071-26-000038.md) | [7,239](/filings/0001437071-26-000064.md) |
| Total liabilities | $m | [5,046](/filings/0001437071-23-000033.md) | [4,502](/filings/0001437071-25-000007.md) | [4,446](/filings/0001437071-24-000016.md) | [4,307](/filings/0001437071-24-000027.md) | [5,225](/filings/0001437071-24-000037.md) | [4,957](/filings/0001437071-26-000015.md) | [5,400](/filings/0001437071-25-000017.md) | [4,691](/filings/0001437071-25-000031.md) | [5,191](/filings/0001437071-25-000051.md) | [5,678](/filings/0001437071-26-000064.md) | [5,395](/filings/0001437071-26-000038.md) | [6,248](/filings/0001437071-26-000064.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [785](/filings/0001437071-24-000037.md) | [783](/filings/0001437071-26-000015.md) | [786](/filings/0001437071-25-000051.md) | [759](/filings/0001437071-25-000051.md) | [857](/filings/0001437071-25-000051.md) | [731](/filings/0001437071-26-000064.md) | [759](/filings/0001437071-26-000064.md) | [709](/filings/0001437071-26-000064.md) | [770](/filings/0001437071-25-000051.md) | [798](/filings/0001437071-26-000064.md) | [876](/filings/0001437071-26-000064.md) | [990](/filings/0001437071-26-000064.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [52.4 d](/filings/0001437071-24-000037.md) | [31.7 d](/filings/0001437071-26-000015.md) | [57.5](/filings/0001437071-25-000017.md) | [33.0 d](/filings/0001437071-25-000031.md) | [30.8 d](/filings/0001437071-25-000051.md) | [61.9 d](/filings/0001437071-26-000015.md) | [19.3](/filings/0001437071-26-000038.md) | [40.6 d](/filings/0001437071-26-000064.md) | [37.3 d](/filings/0001437071-25-000051.md) | [59.8 d](/filings/0001437071-26-000015.md) | [26.7](/filings/0001437071-26-000038.md) | [42.2 d](/filings/0001437071-26-000064.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [34.1](/filings/0001437071-23-000033.md) | [39.6](/filings/0001437071-24-000016.md) | [42.4](/filings/0001437071-24-000027.md) | [45.7](/filings/0001437071-24-000037.md) | [48.5](/filings/0001437071-25-000017.md) | [49.4](/filings/0001437071-25-000031.md) | [56.2](/filings/0001437071-25-000051.md) | [62.8](/filings/0001437071-26-000038.md) | [66.0](/filings/0001437071-26-000064.md) | [67.6](/filings/0001437071-25-000051.md) | [81.9](/filings/0001437071-26-000038.md) | [94.9](/filings/0001437071-26-000064.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 107,640,417 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001437071-26-000064.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.